Stress and stress-induced glucocorticoids (GCs) sensitize drug abuse behavior as well as the neuroinflammatory response to a subsequent pro-inflammatory challenge. Stress also predisposes or sensitizes individuals to develop substance abuse. There is an emerging evidence that glia and glia-derived neuroinflammatory mediators play key roles in the development of drug abuse. Drugs of abuse such as opioids, psychostimulants, and alcohol induce neuroinflammatory mediators such as pro-inflammatory cytokines (e.g. interleukin (IL)-1b), which modulate drug reward, dependence, and tolerance as well as analgesic properties. Drugs of abuse may directly activate microglial and astroglial cells via ligation of Toll-like receptors (TLRs), which mediate the innate immune response to pathogens as well as xenobiotic agents (e.g. drugs of abuse). The present review focuses on understanding the immunologic mechanism(s) whereby stress primes or sensitizes the neuroinflammatory response to drugs of abuse and explores whether stress-and GC-induced sensitization of neuroimmune processes predisposes individuals to drug abuse liability and the role of neuroinflammatory mediators in the development of drug addiction.
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Introduction
Our charge was to discuss whether neuroimmune processes might play a role in the potentiation of drug reward and drug seeking produced by stressors. Stress and stress-induced glucocorticoids (GCs) sensitize drug abuse behavior as well as the neuroinflammatory response to subsequent pro-inflammatory challenges. The central notion to be explored here is that experience of life stressors may induce a vulnerable phenotype characterized, in part, by a neuroimmune microenvironment sensitized to pro-inflammatory stimuli. We will develop the thesis that drugs of abuse (e.g. methamphetamine, morphine and alcohol) may function, in part, as pro-inflammatory stimuli or danger signals to induce neuroinflammatory responses. Therefore, upon exposure to drugs of abuse, a neuroinflammatory cascade ensues, which facilitates drug reward, dependence, and tolerance, as well as modulation of drug-induced analgesia. A central question to be explored here is whether exposure to stressors sensitizes the neuroinflammatory response to drugs of abuse, thereby potentiating the drug-related phenomena noted above. We will present converging evidence that stress-induced sensitization of neuroinflammatory processes may be a key mechanism(s) by which stress predisposes individuals to developing drug abuse. Understanding the central mechanisms by which stress sensitizes (''primes'') the neuroinflammatory response to drugs of abuse may be the key to understand how stress can promote the development of addiction, and as such is the focus of the present review. Clearly, there is an extensive literature that elaborates upon the effects of stress on peripheral immune function. However, the scope of the present review will be restricted to stress-induced modulation of central nervous system (CNS) innate immunity and its potential role in the development of drug addiction.
CNS innate immunity, inflammation and microglia
CNS innate immunity and its primary immune effector cell, microglia, are the key immunologic substrates for understanding how stress and GCs potentiate neuroinflammatory responses to drugs of abuse. Therefore, a brief orientation on microglia will be provided.
Innate immunity is the first line of defense against infection. Within the CNS, microglia, as part of the myeloid lineage of mononuclear phagocytes, constitute the predominant innate immune cell in the brain parenchyma and serve many functions including immunosurveillance of the brain microenvironment for pathogen invasion, cellular debris, apoptotic cells, and alterations in neuronal phenotype (Ransohoff and Cardona, 2010) . It is important to note that other mononuclear phagocytes including meningeal,
